SCHEMBL9045384

SCHEMBL9045384

Cc1ccc(-c2c(Cl)ncnc2NS(=O)(=O)c2ccc3ccccc3c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
HPGD P15428 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
HSD11B1 P28845 1/20 0.46
TSHR P16473 1/20 0.46
MAPT P10636 3/20 0.45
KDM4E B2RXH2 2/20 0.45
LMNA P02545 2/20 0.45
HTT P42858 2/20 0.45
POLB P06746 1/20 0.45
ESR2 Q92731 1/20 0.45
ALPL P05186 1/20 0.45
EDNRA P25101 1/20 0.45
PKM P14618 1/20 0.44
PKLR P30613 1/20 0.44
KAT6A Q92794 1/20 0.44
ATM Q13315 1/20 0.43
FBP1 P09467 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9044255 0.91 ALDH1A1 (0.56) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL9045052 0.87 MEN1 (0.55) ALDH1A1MEN1KMT2AMAPTEDNRA
SCHEMBL9046709 0.83 ALDH1A1 (0.60) ALDH1A1MEN1KMT2AHSD11B1MAPT
SCHEMBL9046700 0.83 EDNRA (0.49) ALDH1A1MEN1KMT2AMAPTEDNRA
SCHEMBL9047567 0.82 EDNRA (0.51) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL9045149 0.81 NPSR1 (0.51) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL9043635 0.81 EDNRA (0.69) EDNRA
SCHEMBL6785011 0.80 EDNRA (0.67) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL9493604 0.80 EDNRA (0.51) ALDH1A1MEN1KMT2AMAPTEDNRA
SCHEMBL9047803 0.79 PKM (0.55) ALDH1A1MEN1KMT2AHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0510526-B1 Use of sulfonamides as drug and new sulfonamides HOFFMANN LA ROCHE (CH) 1996-12-04 EP disclosed
US-5270313-A Treatment of circulatory disorders HOFFMANN-LA ROCHE INC. (US) 1993-12-14 US disclosed
EP-0510526-A1 Use of sulfonamides as drug and new sulfonamides F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1992-10-28 EP disclosed